Cargando…

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost

BACKGROUND: Local recurrence is the most common pattern of failure in head and neck cancer. It can therefore be hypothesised that some of these patients would benefit from an intensified local treatment, such as radiation dose escalation of the primary tumour. This study compares treatment and toxic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Embring, Anna, Onjukka, Eva, Mercke, Claes, Lax, Ingmar, Berglund, Anders, Friesland, Signe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082532/ https://www.ncbi.nlm.nih.gov/pubmed/37029424 http://dx.doi.org/10.1186/s13014-023-02256-x

Ejemplares similares

Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects
por: Embring, Anna, et al.
Publicado: (2023)

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects
por: Embring, Anna, et al.
Publicado: (2021)

Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
por: Embring, Anna, et al.
Publicado: (2020)

Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
por: Onjukka, Eva, et al.
Publicado: (2020)

Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial
por: Mercke, Claes, et al.
Publicado: (2023)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
por: Vempati, Prashant, et al.
Publicado: (2020)

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung Cancer
por: Yang, Wenjuan, et al.
Publicado: (2017)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Dose‐escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs
por: Meier, Valeria, et al.
Publicado: (2022)

Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution
por: Cheung, Elki Sze-Nga, et al.
Publicado: (2023)

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose‐escalation feasibility study
por: Cilla, Savino, et al.
Publicado: (2018)

Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical
por: Stefanowicz, Sarah, et al.
Publicado: (2020)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature
por: Jensen, Garrett Lee, et al.
Publicado: (2021)

IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study
por: Lőcsei, Zoltán, et al.
Publicado: (2021)

High dose simultaneous integrated boost for node positive cervical cancer
por: Jayatilakebanda, Iresha, et al.
Publicado: (2021)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting
por: Wittenstein, Olaf, et al.
Publicado: (2022)

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Correction to: High dose simultaneous integrated boost for node positive cervical cancer
por: Jayatilakebanda, Iresha, et al.
Publicado: (2021)

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost
por: Kim, Myungsoo, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
por: Olsén, Johan Staby, et al.
Publicado: (2022)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017)

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost
por: Pinkawa, Michael, et al.
Publicado: (2012)

A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer
por: Li, Chen, et al.
Publicado: (2019)

CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy
por: Haas, Jonathan Andrew, et al.
Publicado: (2012)

The effect of escalating the boost dose for patients with involved resection margin after breast-conserving surgery
por: Park, Sunmin, et al.
Publicado: (2018)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
por: Aly, Moamen M.O.M., et al.
Publicado: (2015)

An imaging evaluation of the simultaneously integrated boost breast radiotherapy technique
por: Turley, Jessica, et al.
Publicado: (2015)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rp10b7mpavgc5268e1q12gds98